9 Feb 2016
Author(s): 
Angela K. Shen, Jonathan M. Weiss, Jon Kim Andrus, Clint Pecenka, Deborah Atherly, Katherine Taylor and Michael McQuestion

Since the mid-2000s low- and lower-middle-income countries have been focusing on developing and using evidence for immunization policy making, with an increasing emphasis on cost-effectiveness analysis, program costing, and financial flows—particularly for the introduction of newer, more expensive vaccines.